199 related articles for article (PubMed ID: 34236488)
1. Neuroendocrine neoplasms of the gallbladder: early detection and surgery is key to improved outcome.
Gogna S; Samson D; Gachabayov M; Rojas A; Felsenreich DM; Koo D; Gu K; Quintero L; Miller KR; Azim A; Da Eric Dong X
Langenbecks Arch Surg; 2022 Feb; 407(1):197-206. PubMed ID: 34236488
[TBL] [Abstract][Full Text] [Related]
2. Comparative prognosis and risk assessment in gallbladder neuroendocrine neoplasms versus adenocarcinomas.
Zhao ZH; Huang Y; Jiang C; Lv GY; Wang M
Front Endocrinol (Lausanne); 2024; 15():1326112. PubMed ID: 38390209
[TBL] [Abstract][Full Text] [Related]
3. Nomograms for Predicting Survival Outcomes in Patients with Neuroendocrine Neoplasms of the Gallbladder Undergoing Primary Tumor Resection: A Population-Based Study.
Zhang YR; Hu GC; Fan MK; Yao HL; Jiang C; Shi HY; Lin R
Curr Oncol; 2023 Feb; 30(3):2889-2899. PubMed ID: 36975434
[TBL] [Abstract][Full Text] [Related]
4. The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database.
Zheng BH; Zhang C; Wan WZ; Sun WT; Cheng X; Ni XJ; Ni XL; Suo T; Liu H; Shen S; Liu HB
BMC Surg; 2022 Jun; 22(1):253. PubMed ID: 35768809
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy.
Eltawil KM; Gustafsson BI; Kidd M; Modlin IM
J Clin Gastroenterol; 2010; 44(10):687-95. PubMed ID: 20375728
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Clinical Features and Outcomes of Gallbladder Neuroendocrine Carcinoma with Those of Adenocarcinoma: A Propensity Score-Matched Analysis.
Do MY; Jang SI; Kang HP; Kim EJ; Lee KJ; Park GE; Lee SJ; Lee DK; Woo SM; Cho JH
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572940
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms: A Large-Volume Multicenter Study During One Decade.
Wang Y; Huang B; Fu Q; Wang J; Ye M; Hu M; Qu K; Liu K; Hu X; Wei S; Sun K; Xiao W; Zhang B; Li H; Li J; Zhang Q; Liang T
Ann Surg Oncol; 2022 Nov; 29(12):7619-7630. PubMed ID: 35849293
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine neoplasms of the gallbladder: A single institute analysis of outcomes and prognostic factors.
Nandy K; Patkar S; Yadav S; Ostwal V; Ramaswamy A; Bhargav P; Goel M
J Surg Oncol; 2024 May; 129(6):1121-1130. PubMed ID: 38348696
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and survival for gallbladder NEN: a population-based study.
Cen D; Liu H; Wan Z; Lin Z; Wang Y; Xu J; Liang Y
Endocr Connect; 2019 Sep; 8(9):1273-1281. PubMed ID: 31398710
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis.
Komiyama S; Okusaka T; Maruki Y; Ohba A; Nagashio Y; Kondo S; Hijioka S; Morizane C; Ueno H; Sukeda A; Mizui T; Takamoto T; Nara S; Ban D; Esaki M; Hiraoka N; Shimada K
Intern Med; 2024 Apr; 63(7):891-901. PubMed ID: 37612088
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population-based study.
Zhang P; Wang W; Lu M; Zeng C; Chen J; Li E; Tan H; Wang W; Yu X; Tang Q; Zhao J; Shen L; Li J
Cancer Med; 2018 Sep; 7(9):4361-4370. PubMed ID: 30062861
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and prognostic factors of patients with primary gallbladder neuroendocrine carcinomas.
Wang W; Yang CX; Yu XZ; Zhang SL; Wang J; Wang J
J Dig Dis; 2022 Mar; 23(3):166-173. PubMed ID: 35187836
[TBL] [Abstract][Full Text] [Related]
14. Mixed Intraepithelial Neoplasia-Well-Differentiated Neuroendocrine Tumor of the Gallbladder: A Hitherto Unreported Combination.
Kővári B; Turkevi-Nagy S; Lauwers GY; Jiang K
Int J Surg Pathol; 2021 Sep; 29(6):685-689. PubMed ID: 33423570
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder.
Yun SP; Shin N; Seo HI
World J Gastroenterol; 2015 Jan; 21(1):269-75. PubMed ID: 25574101
[TBL] [Abstract][Full Text] [Related]
16. Gallbladder neuroendocrine carcinoma diagnosis, treatment and prognosis based on the SEER database: A literature review.
Cai XC; Wu SD
World J Clin Cases; 2022 Aug; 10(23):8212-8223. PubMed ID: 36159526
[TBL] [Abstract][Full Text] [Related]
17. Differential and prognostic MRI features of gallbladder neuroendocrine tumors and adenocarcinomas.
Bae JS; Kim SH; Yoo J; Kim H; Han JK
Eur Radiol; 2020 May; 30(5):2890-2901. PubMed ID: 32025835
[TBL] [Abstract][Full Text] [Related]
18. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
Masui T; Ito T; Komoto I; Uemoto S;
BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].
Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929
[No Abstract] [Full Text] [Related]
[Next] [New Search]